Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board hears calls to ease pharmacy barriers to buprenorphine as providers, advocates describe denied fills and delays
Summary
Clinicians and addiction specialists told the California Board of Pharmacy that pharmacy refusals, stockouts and strict application of long‑standing "red flag" guidance are delaying or blocking patient access to buprenorphine and other opioid‑use‑disorder medications.
Emergency and addiction clinicians, patient navigators and national addiction organizations told the California Board of Pharmacy on Feb. 6 that pharmacies are often the bottleneck when patients started on buprenorphine in emergency departments try to fill their first prescription.
Clinicians described repeated episodes in which patients arriving at community pharmacies — sometimes in withdrawal or with traumatic social circumstances — were refused fills, told the pharmacy had no stock, or faced denials because pharmacists applied “red flag” rules without contacting prescribers. Tommy Trevino, a substance‑use navigator at UC Davis Medical Center, said a patient he accompanied to a pharmacy was refused and staff threatened to call police; he said the episode ended only after the team returned to the hospital and arranged medication by other means.
Why it matters: Buprenorphine and other medications for opioid use disorder (MOUD) are proven to reduce overdose risk. Presenters argued that when community pharmacists treat buprenorphine…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat

